The timeline for the final rule is not specified, but based on typical FDA rulemaking, a final decision could come in late 2026 or early 2027
Kidney Dysfunction: High doses over a prolonged period could potentially strain the kidneys, especially in individuals with pre-existing kidney conditions
The company just unveiled Lemme Metabolism, daily capsules formulated to support weight maintenance after weight loss, promote the gut-metabolic axis and reduce unhealthy visceral fat
ScienceAlert reported on May 28, 2026, that a 2025 NYU study found that a bariatric surgery may lead to greater real-world weight loss than GLP-1 medicines like Ozempic
Lets break it down: The Science Stuff (Simplified) Semaglutide mimics one hormone (GLP-1) Tirzepatide mimics two (GLP-1 + GIP) Both help regulate appetite, insulin, and blood sugar They're available as injectables , and in some programs including Josie you may be offered compounded oral tablets if appropriate